Product NDC: | 47335-178 |
Proprietary Name: | Oxaliplatin |
Non Proprietary Name: | Oxaliplatin |
Active Ingredient(s): | 100 mg/20mL & nbsp; Oxaliplatin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47335-178 |
Labeler Name: | Sun Pharma Global FZE |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078818 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090819 |
Package NDC: | 47335-178-40 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (47335-178-40) > 20 mL in 1 VIAL, SINGLE-USE |
NDC Code | 47335-178-40 |
Proprietary Name | Oxaliplatin |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (47335-178-40) > 20 mL in 1 VIAL, SINGLE-USE |
Product NDC | 47335-178 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxaliplatin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090819 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharma Global FZE |
Substance Name | OXALIPLATIN |
Strength Number | 100 |
Strength Unit | mg/20mL |
Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |